does semaglutide cause vision loss linked to higher risk of problems, FDA data analysis shows Risk for a rare, potentially

Data on the involvement of GLP-1R in various patterns of dependence on chemicals, including alcohol, nicotine, psychostimulants, and opioids, confirm the high potential of GLP-1RAs

SURPASS-2 data shows Mounjaro 15 mg produces nearly double the weight loss of semaglutide injection, making it the preferred choice when weight management is the primary goal

Key findings from clinical trials include: Reductions in waist circumference, an indirect marker of abdominal fat Improvements in metabolic markers associated with visceral adiposity (HbA1c, lipid profiles, liver enzymes) Decreased hepatic fat content in patients with fatty liver disease It is important to understand that GLP-1 medications do not 'burn' fat through thermogenesis or direct lipolysis

Nieman, K

Even so, experts caution that these medications are not foolproof and using them the wrong way can undermine results or even create new health problems

The Most Common GLP-1 Weight Loss Medications Semaglutide (Wegovy and Ozempic) Semaglutide was the first GLP-1 medication to really change the weight loss game